SEC Form D · filed November 6, 2019
RedHill Biopharma Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (41)
Shmuel Cabilly · Tel Aviv, L3DirectorJune D. Almenoff · Tel Aviv, L3ExecReza D. Fathi · Tel Aviv, L3ExecGilead D. Raday · Tel Aviv, L3ExecEric Swenden · Tel Aviv, L3DirectorGuy D. Goldberg · Tel Aviv, L3ExecMicha D. Ben Chorin · Tel Aviv, L3ExecAlla D. Felder · Tel Aviv, L3DirectorAdi D. Frish · Tel Aviv, L3ExecKenneth Reed · Tel Aviv, L3DirectorRick D. Scruggs · Tel Aviv, L3Exec · DirectorDror Ben-Asher · Tel Aviv, L3Exec · DirectorOfer Tsimchi · Tel Aviv, L3DirectorAldo Zini · Turtle Creek, PADirectorGreg Schupra · Pontiac, MIExecBruce W. Snyder · Seattle, WAExec · DirectorPeter R. Kagan · Tulsa, OKExecMichael B. Rozmajzl · Roswell, GAExecIngrid Mulder · Amstelveen, P7Exec · DirectorBrandon Contino · Turtle Creek, PAExecGaurav Gambhir · Philadelphia, PADirectorMohamed Arafa · Amstelveen, P7DirectorJoshua E. Wyss · Mill Valley, CADirectorKen Johnson · Franklin, MIDirectorCleon N. Daskalakis · Boston, MAExecJeffrey N. Vale · Atlanta, GAExecNicolas D. Weinstein · TEL AVIV, L3DirectorJosh S. Stein · Palo Alto, CADirectorJesse S. Robbins · Palo Alto, CAExecSteven A. Anderson · SOUTH PASADENA, CADirectorJohn C. Power · VACAVILLE, CAExec · DirectorBrian C. Power · VACAVILLE, CADirectorLee Shapiro · Northbrook, ILExecJacob S. Horne · SAN FRANCISCO, CAExecDavid Meredith · NEWPORT BEACH, CAExecRick Taketa · CORONA DEL MAR, CAExecDarren O'Brien · WAN CHAI, Hong KongDirectorSimone Blank · NEWPORT BEACH, CAExec · DirectorJost Fischer · NEWPORT BEACH, CADirectorDouglas Buchalter · Asheville, NCExecNicolas D. Weinstein · TEL AVIV, L3Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗